LANDMARK LANCET STUDY OF 32,862 PEOPLE: CHEMO KILLS HALF OF CANCER PATIENTS

This study comes from researchers by the Public Health England and Cancer Research UK and was published in the medical journal The Lancet OncologyThe study gives a glimpse into the complete and total failure of inferior toxic solutions to cancer. Looking at the 30-day mortality rate for patients who had undergone chemotherapy for breast cancer (23,228 patients) and lung cancer (9,634 patients).

The study's carefully worded conclusion stated: 

"Our findings show that several factors affect the risk of early mortality of breast and lung cancer patients in England and that some groups are at a substantially increased risk of 30-day mortality."

While no major paradigm shifts will happen from the publication of this Lancet study, the public work now adds to a massive body of data, evidence and personal experience pointing to better methods than deadened chemotherapy and toxic cancer solutions. What no study has addressed or looked at to date is the poor, compromised quality of life for the survivors of toxic cancer solutions. 

Read more HERE